374 related articles for article (PubMed ID: 24118939)
1. The status of serum vitamin D in patients with active Behcet's disease compared with controls.
Khabbazi A; Rashtchizadeh N; Ghorbanihaghjo A; Hajialiloo M; Ghojazadeh M; Taei R; Kolahi S
Int J Rheum Dis; 2014 May; 17(4):430-4. PubMed ID: 24118939
[TBL] [Abstract][Full Text] [Related]
2. The effect of 25(OH)D on endothelial and immunological markers in Behçet's disease.
Güngör Ş; Gökdemir G; Çiçek YG; Topal İO; Canat D
J Dermatolog Treat; 2016; 27(3):254-9. PubMed ID: 26368304
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D status in Algerian Behçet's disease patients: an immunomodulatory effect on NO pathway.
Djeraba Z; Benlabidi F; Djaballah-Ider FZ; Medjeber O; Arroul-Lammali A; Belguendouz H; Otmani F; Touil-Boukoffa C
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):243-250. PubMed ID: 28532201
[TBL] [Abstract][Full Text] [Related]
4. The performance of different classification criteria in paediatric Behçet's disease.
Batu ED; Sönmez HE; Sözeri B; Butbul Aviel Y; Bilginer Y; Özen S
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):119-123. PubMed ID: 28406761
[TBL] [Abstract][Full Text] [Related]
5. The association between vitamin D level and Behcet's disease: a meta-analysis.
Pitukweerakul S; Sinyagovskiy P; Prachuapthunyachart S
Int J Rheum Dis; 2017 Dec; 20(12):2217-2218. PubMed ID: 28608505
[No Abstract] [Full Text] [Related]
6. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between serum IL-9 levels and Behçet's disease.
Nouri-Vaskeh M; Malek Mahdavi A; Khabbazi A; Jadideslam G
Immunol Lett; 2019 Jul; 211():23-27. PubMed ID: 31095970
[TBL] [Abstract][Full Text] [Related]
8. Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease.
Do JE; Kwon SY; Park S; Lee ES
Rheumatology (Oxford); 2008 Jun; 47(6):840-8. PubMed ID: 18411217
[TBL] [Abstract][Full Text] [Related]
9. Increased serum interleukin-32 levels in patients with Behçet's disease.
Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
[TBL] [Abstract][Full Text] [Related]
10. Higher 25-hydroxyvitamin D level is associated with increased risk for Behçet's disease.
Zhong Z; Su G; Du L; Zhou Q; Li F; Chi W; Liu S; Zhang M; Zuo X; Yang P
Clin Nutr; 2021 Feb; 40(2):518-524. PubMed ID: 32593521
[TBL] [Abstract][Full Text] [Related]
11. Effect of vitamin D deficiency and replacement on endothelial functions in Behçet's disease.
Can M; Gunes M; Haliloglu OA; Haklar G; Inanç N; Yavuz DG; Direskeneli H
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S57-61. PubMed ID: 23020973
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D3 ameliorates herpes simplex virus-induced Behçet's disease-like inflammation in a mouse model through down-regulation of Toll-like receptors.
Choi B; Lee ES; Sohn S
Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S13-9. PubMed ID: 21269574
[TBL] [Abstract][Full Text] [Related]
13. Comparison of existing disease activity indices in the follow-up of patients with Behçet's disease.
Shahram F; Khabbazi A; Nadji A; Ziaie N; Banihashemi AT; Davatchi F
Mod Rheumatol; 2009; 19(5):536-41. PubMed ID: 19590934
[TBL] [Abstract][Full Text] [Related]
14. An Exploration of Some Predictors of Quality of Life-Related to the Innate Immune System, Inflammation, and Disease Activity in Patients with Behcet's Syndrome: An Analytical Cross-sectional Study.
Faghfouri AH; Shoura SMS; Papi S; Khabbazi A; Baradaran B; Badpeyma M; Faghfuri E
Curr Rheumatol Rev; 2024; 20(2):200-207. PubMed ID: 37691223
[TBL] [Abstract][Full Text] [Related]
15. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 mRNA expression and serum levels in Behçet's disease.
Jadideslam G; Kahroba H; Ansarin K; Sakhinia E; Abhar A; Alipour S; Farhadi J; Seydi Shirvani S; Nouri-Vaskeh M; Mousavi S; Khabbazi A
Cytokine; 2020 Mar; 127():154994. PubMed ID: 31951967
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of depression, anxiety and fatigue in patients with Behçet's disease.
Can Sandikci S; Colak S; Omma A; Enecik ME
Int J Rheum Dis; 2019 Jun; 22(6):974-979. PubMed ID: 30398004
[TBL] [Abstract][Full Text] [Related]
18. Fractalkine (CX3CL1) levels in patients with Behçet's disease and neuro-Behçet's disease.
Ceyla I; Tuba TK; Adisen E; Banu O; Isil F; Ali GM; Turgut I; Banu B
J Neurol Sci; 2012 Apr; 315(1-2):120-2. PubMed ID: 22177089
[TBL] [Abstract][Full Text] [Related]
19. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations.
Fawzy RM; Said EA; Mohamed SM; Fouad NA; Akl EM
Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D status in patients with Behcet's Disease.
Karatay S; Yildirim K; Karakuzu A; Kiziltunc A; Engin RI; Eren YB; Aktas A
Clinics (Sao Paulo); 2011; 66(5):721-3. PubMed ID: 21789370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
